Medical Cannabis, Cannabinoids & Opioids

The PharmaBoardroom Medical Cannabis, Cannabinoids and Opioids collection covers the legal and regulatory frameworks governing these product categories across key markets worldwide. Each guide is developed with a leading local law firm and addresses the specific licensing, prescribing, distribution, marketing and import and export rules that apply.

Medical cannabis and cannabinoid regulation has changed rapidly across multiple markets in recent years, with new frameworks introduced in Germany, the UK, and several other European and Latin American countries. Opioid prescribing and distribution rules remain tightly controlled across most markets, with significant variation in what is permitted.

These guides give regulatory affairs and compliance teams the country-specific information they need to operate within the applicable legal framework. Browse below to find the guide for your target market.